ApoB

Apolipoprotein B (ApoB) is a protein that sits on the surface of certain cholesterol-carrying particles in your blood, specifically LDL, VLDL, IDL, and lipoprotein(a). These particles are considered harmful because they can deliver cholesterol into the walls of your arteries, triggering the formation of plaque over time. What makes ApoB unique is that each of these particles carries exactly one ApoB protein, making it a direct count of the number of potentially harmful particles in your bloodstream.

Think of your bloodstream as a highway. The particles that carry cholesterol are like delivery trucks. ApoB tells you how many trucks are on the road, not how much cholesterol they’re carrying, but how many vehicles could cause damage. The more trucks there are, the higher the chances they’ll drop off their cargo into your artery walls, eventually forming plaque. This process, known as atherosclerosis, can lead to heart attacks, strokes, and other cardiovascular problems.

Traditional cholesterol tests, like LDL cholesterol (LDL-C), only measure the total weight of cholesterol inside those particles. But this can be misleading. Someone can have a normal LDL-C number but still have a large number of smaller, denser LDL particles, which are more likely to cause damage. That’s where ApoB shines: it measures particle count, not just cholesterol weight, giving a more accurate picture of your risk. This is especially important for people with insulin resistance, metabolic syndrome, or diabetes, where traditional cholesterol tests often underestimate risk.

ApoB has been shown in large studies to be a better predictor of cardiovascular risk than LDL-C or total cholesterol. It’s especially helpful for personalizing treatment plans, for example, determining whether your statin or PCSK9 inhibitor is actually reducing risk at the particle level, not just lowering cholesterol numbers on paper.

For people aiming to prevent heart disease and extend healthspan, many experts now recommend targeting ApoB levels below 60 mg/dL, lower than the standard clinical cutoff of 80 mg/dL. This more aggressive goal may reduce long-term cardiovascular risk even further and is especially worth considering if you have other risk factors like high blood pressure, a family history of heart disease, or chronic inflammation.